Research on the potentiators of HSV-specific thymidine kinase for the purpose of their application to gene therapy and antiviral therapy

HSV特异性胸苷激酶增强剂的研究及其在基因治疗和抗病毒治疗中的应用

基本信息

  • 批准号:
    09672276
  • 负责人:
  • 金额:
    $ 1.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

So far, we found three compounds which exerted synergistic antiherpetic activities with acyclovir (ACV) and ganciclovir(GCV). Especially, of these agents, two diterpenoids, scopadulciol (SDC) and ponicidin (PND), potentiated the cell-killing activity of ACV and GCV in herpes simplex virus type 1(HSV-1) thymidine kinase (TK)-expressing cells. We report about these in detail as follows A naturally occuring flavone, 5,6,7-irimethoxyflavone (TMF), isolated from a plant Gallicarpa japonica, was subjected to antiviral assays . The agent exhibited inhibitory effects on HSV- 1 . TMF and ACV were synergic in their anti-HSV activities, During the evaluation of the effect of ponicidin(PND), which was isolated from a plant Rabdosia ternifolia . on the antiviral activities of ACV and GCV, the compound was found to preferentially activate HSV- 1 -specific TK but not cellular kinases. ln cultured human cancer cells transfected with HSV- 1 TK gene, cytotoxicities of ACV and GCV was strongly potentiated by PND.When the stability of the bioactivity of PND in the blood of mice was determined, the substance showed long-lasting effects on the potentiation of antiherpetic and cytotoxic activities of GCV.Another diterpenoid, SDC isolated from Scoparia dulcis, was also demonstrated as a potentiator of antiherpetic and cell-killing activities of ACV and GCV in in vilro experimental models. These data suggest that combined use of PND or SDC with ACV/GCV will be effective for cancer gene therapy because of more rapid and enhanced tumor elimination.
迄今为止,我们发现三个化合物与阿昔洛韦(ACV)和更昔洛韦(GCV)具有协同抗疱疹活性。特别是,这些代理商,两个二萜类化合物,东莨菪碱(SDC)和ponicidin(PND),加强ACV和GCV在单纯疱疹病毒1型(HSV-1)胸苷激酶(TK)表达细胞的细胞杀伤活性。我们详细报道如下:一种天然存在的黄酮,5,6,7-三甲氧基黄酮(5,6,7-trimethoxyflavone,5-trimethoxyfl该试剂对HSV- 1表现出抑制作用。从三叶香茶菜中提取的Ponicidin(PND)对HSV的抑制作用与ACV有协同作用。在ACV和GCV的抗病毒活性上,发现该化合物优先激活HSV- 1特异性TK,但不激活细胞激酶。在体外培养的转染HSV- 1 TK基因的人癌细胞中,PND能显著增强ACV和GCV的细胞毒作用,PND在小鼠血液中的生物活性稳定性测定表明,PND对GCV的抗疱疹和细胞毒作用具有持久的增强作用。在体外实验模型中,也证明了作为ACV和GCV的抗疱疹和细胞杀伤活性的增强剂。这些数据表明,联合使用PND或SDC与ACV/GCV将是有效的癌症基因治疗,因为更快速和增强的肿瘤消除。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hayashi,T.,Hayashi,K.,Asano,S. et al.: "Towards Natural Medicine Research in the 21st Century" Elsevier Science Publisher, (1998)
林,T.,林,K.,浅野,S.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Hayashi, K.Hayashi, S.Asano et al.: "Towards Natural Medicine Research in the 21st Century" E lsevier Science Publisher, 9 (1998)
T.Hayashi、K.Hayashi、S.Asano 等人:“迈向 21 世纪的自然医学研究”Elsevier Science Publisher,9 (1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Hayashi, T.Hayashi, H.Otsuka, Y.Takeda: "Antiviral activity of 5,6,7-trimethoxyflavono and its potentiation of antiherpes activity of acyclovir" Journal of Antimicrobial Chemotherapy. 39・6. 821-824 (1997)
K.Hayashi、T.Hayashi、H.Otsuka、Y.Takeda:“5,6,7-三甲氧基黄酮的抗病毒活性及其对阿昔洛韦抗疱疹活性的增强”,抗菌化疗杂志 39・6。 )
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toshimitsu Hayashi et al.: Bioactive diterpenoids from a herb, Scoparia dulcis L.Toward Natural Medicine Research in the 21st Century. Elsevier Science B.V., 9 (1998)
Toshimitsu Hayashi 等人:来自草本植物 Scoparia dulcis L 的生物活性二萜类化合物。走向 21 世纪的自然医学研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Hayashi,T.Hayashi,H.Otsuka,Y.Takeda: "Antiviral activity of 5,6,7-trimethoxyflavone and its potentiation of antiherpes activity of acyclovir" Journal of Antimicrobial Chemotherapy. 39・6. 821-824 (1997)
K. Hayashi、T. Hayashi、H. Otsuka、Y. Takeda:“5,6,7-三甲氧基黄酮的抗病毒活性及其对阿昔洛韦抗疱疹活性的增强”《抗菌化疗杂志》39・6。 )
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HAYASHI Kyoko其他文献

HAYASHI Kyoko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HAYASHI Kyoko', 18)}}的其他基金

Characterization of the NS1 mutants induced by a chemical substance
化学物质诱导的 NS1 突变体的表征
  • 批准号:
    25460206
  • 财政年份:
    2013
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Attenuatio of influenza virus by drug treatment and elucidation of mechanism of the attenuation
药物治疗对流感病毒的减毒作用及减毒机制的阐明
  • 批准号:
    21590153
  • 财政年份:
    2009
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation of anti-human coronavirus agents
抗人类冠状病毒药物的评价
  • 批准号:
    16590434
  • 财政年份:
    2004
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Enhancement of anticancer effects by HSV-TK potentiators and evaluation of navel liposome vectors in MSV-TK/prodding gene therapy
HSV-TK增强剂增强抗癌作用以及MSV-TK/刺激基因治疗中脐脂质体载体的评价
  • 批准号:
    12672210
  • 财政年份:
    2000
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Contributions of host and gut microbial mediated metabolism to the antiviral activity of elderberry
宿主和肠道微生物介导的代谢对接骨木浆果抗病毒活性的贡献
  • 批准号:
    10723102
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
Identification and characterization of the human factors targeted by the Nucleic Acid Polymers (NAP) responsible for its antiviral activity against HBV and HDV.
核酸聚合物(NAP)针对 HBV 和 HDV 抗病毒活性的人为因素的鉴定和表征。
  • 批准号:
    558342-2020
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Alliance Grants
Contributions of host and gut microbial mediated metabolism to the antiviral activity of elderberry
宿主和肠道微生物介导的代谢对接骨木浆果抗病毒活性的贡献
  • 批准号:
    10537933
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
Development of new visible light responsive organic semiconductor photocatalyst and its evaluation of antibacterial and antiviral activity
新型可见光响应有机半导体光催化剂的研制及其抗菌抗病毒活性评价
  • 批准号:
    22K04827
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
抗体效应子功能多样性对原位抗病毒活性的影响
  • 批准号:
    10258146
  • 财政年份:
    2021
  • 资助金额:
    $ 1.92万
  • 项目类别:
Mechanism of Light-activated Antiviral Activity of Conjugated Polyelectrolyte Polymers and Oligomers
共轭聚电解质聚合物和低聚物的光激活抗病毒活性机制
  • 批准号:
    2105171
  • 财政年份:
    2021
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Continuing Grant
Identification and characterization of the human factors targeted by the Nucleic Acid Polymers (NAP) responsible for its antiviral activity against HBV and HDV.
核酸聚合物(NAP)针对 HBV 和 HDV 抗病毒活性的人为因素的鉴定和表征。
  • 批准号:
    558342-2020
  • 财政年份:
    2021
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Alliance Grants
Antiviral Activity In Situ
原位抗病毒活性
  • 批准号:
    10475294
  • 财政年份:
    2021
  • 资助金额:
    $ 1.92万
  • 项目类别:
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
抗体效应子功能多样性对原位抗病毒活性的影响
  • 批准号:
    10670229
  • 财政年份:
    2021
  • 资助金额:
    $ 1.92万
  • 项目类别:
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
抗体效应子功能多样性对原位抗病毒活性的影响
  • 批准号:
    10475274
  • 财政年份:
    2021
  • 资助金额:
    $ 1.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了